Posts Tagged ‘Ketamine’

Treatment Resistant Depression is Apparently a Thing

Monday, February 6th, 2023

Psychiatrists like to fund research studies for so-called “Treatment Resistant Depression” (TRD). They say that if someone has been given antidepressant drugs but their symptoms haven’t improved, they may have treatment-resistant depression.

Of course, the treatments of choice for TRD are more psychiatric drugs, such as ketamine and esketamine (dissociative anesthetics), olanzapine (an atypical anti-psychotic drug) and fluoxetine (Prozac). Some claim that Transcranial Magnetic Stimulation (TMS) or electroconvulsive therapy (ECT or shock treatment) “work” for this. Of course, all these “treatments” just knock your brain for a loop, so you don’t feel depressed, or much of anything anymore. None of these actually address the root causes for these symptoms, which psychiatrists conveniently forget to tell you.

One study suggests that between 29% and 46% of patients are still depressed after taking antidepressant drugs. Another study claims 20%-60% do not respond to psychiatric drugs. Well, we’ve known for years that not only is there no such “mental illness” as depression, but also that these mind-altering drugs don’t help.

People can, of course, experience symptoms commonly labeled as depression. In fact, there are hundreds of genuine medical conditions which can produce such mental symptoms — each of which has clinical tests and recognized medical treatments which do not involve psychiatric drugs.

While the fraudulent psychiatric “brain chemical imbalance” theory has been debunked for many years, it has been held firmly in place by the psycho-pharma public relations machine in order to sell more harmful and addictive psychiatric drugs. These drugs make patients for life since the drugs do not cure anything and have devastating side effects.

Psychiatrists have known since the beginning of psychopharmacology that their drugs do not cure any disease, and that antidepressants do not have any legitimate medical value. These are just public relations theories to support the marketing and sale of drugs. This is why the words “depressed” or “depressive” occur 77 times in various fraudulent diagnoses in the Diagnostic and Statistical Manual of Mental Disorders (DSM), in a vain attempt to legitimize this so-called “disease.”

Troubled patients being misled about what causes their problems and being told that they need to take a psychotropic drug to “correct” this is a form of coercion. Giving patients such misinformation prevents their making an informed decision and has already resulted in many millions of people taking antidepressants or other psychotropic drugs with harmful side effects, erroneously believing these would “correct” something that simply never existed.

These drugs mask the real cause of problems in life and debilitate the individual, so denying him or her the opportunity for real recovery and hope for the future. This is the real reason why psychiatry is a violation of human rights. Psychiatric treatment is not just a failure — it is routinely destructive to the individual and one’s mental health.

If you know someone who has bought into these lies, suggest they investigate non-psychiatric, non-drug alternatives. Contact your local, state and federal representatives and demand that they stop government funding of these drugs.

Local psychiatrist known for giving medical marijuana cards could lose her license

Monday, October 17th, 2022

Dr. Zinia Thomas, a psychiatrist in St. Louis, Missouri, was arrested September 1, 2022 on felony drug charges for illegally possessing marijuana, which she had allegedly attempted to sell.

Apparently she had also been previously investigated for improperly issuing Missouri medical marijuana cards.

In addition to marijuana, Dr. Thomas also promotes the use of ketamine, a psychedelic anesthetic also called a “date-rape” drug. Basically it knocks you out so you don’t feel so depressed anymore. You don’t feel much of anything, actually, since you’ve just shot up an anesthetic. Psychiatrists pushing ketamine are shameful drug pushers who are making a buck off people’s misfortune.

Psychiatry, in spite of diagnosing cannabis use as a mental disorder, also pushes cannabis as a treatment for mental trauma. In Missouri, “psychiatric disorders” are a top reason that patients are approved for a medical marijuana license.

Medical marijuana sales in Missouri are above $200 million since it went on sale in October 2020. Roughly 17% of approximately 200,000 medical marijuana cards issued in Missouri are for so-called psychiatric disorders, which must be diagnosed by a state-licensed psychiatrist. One popular diagnostic code from the Diagnostic and Statistical Manual of Mental Disorders (DSM) is “Unspecified mental disorder”. Note also that there are 32 diagnostic codes for various mental problems with marijuana use and abuse, including the ever popular “Unspecified cannabis-related disorder”. Notice that a psychiatrist can recommend the issuance of a Missouri medical marijuana card to someone to treat their problems from using marijuana. How convenient is that?

False information published by the Federal Substance Abuse and Mental Health Services Administration claimed that “19.9 percent of American adults in the United States (45.1 million) have experienced mental illness over the past year.”

This popular statistic, pushed by the psychiatric industry to justify their existence, is completely false or, at best, highly questionable. The apparent epidemic of “mental illness” is because the psychiatric industry, working with the pharmaceutical industry and the Food and Drug Administration, invents new fraudulent disorders for which more drugs can be prescribed; all-encompassing disorders such as the one noted above, “Unspecified mental disorder.” People can have serious problems in life; these are not, however, some unspecified mental illness caused by a deficiency of marijuana.

The psychiatric industry today has jumped on the cannabis bandwagon for several reasons. Psychiatrists are embracing all things marijuana because they are getting so many patients with marijuana-related problems such as addiction and psychosis.

When psychiatric treatments fail and psychotropic drug patents run out, there are usually efforts to resurrect old treatments as “new miracles,” such as psychedelics. There is a hefty body of evidence showing the lack of science behind psychiatry’s diagnostic system that leads to unworkable and potentially damaging treatments including psychedelics. The psychedelic “therapy” industry is predicted to reach $7 billion by 2027, a powerful draw for a therapist without scruples.

Governments keep investing billions of dollars into psychiatry to improve conditions that psychiatrists admit they cannot cure. Promises are repeatedly made to improve the mental health of the country but the opposite has occurred. The rate of mental trauma keeps soaring, and with it, demands for a blank check for more funding. Contact your local, state and federal officials and demand that they stop funding harmful psychiatric “treatments,” and that psychiatry is held accountable for their harm.

Turn On, Tune In, Drop Out, Psych Out

Monday, October 19th, 2020

Over the last few years there has been a surge of interest and media in using psychedelics as psychiatric drugs to “treat” so-called “mental illness.” Need we actually say that this is an insanely bad idea?

For example, psychiatrists have been demanding funds for research using LSD,psilocybin (magic mushroom), MDMA (Ecstasy), marijuana,ketamine and kratom.

Even if psychedelic drugs are administered to consenting subjects, such research demonstrates a fundamental disregard for human life because of the drugs’ mind-altering properties, born out by the psychiatric-intelligence community’s past research of LSD, psilocybin and amphetamines. Not only does psychedelic drug abuse endanger one’s health, but also one’s learning rate, attitudes, personality and overall mental acuity.

Thirty-two million people in the US are reported users of psychedelic drugs, while reports of riots, violence, suicide, and psychotic behavior are rising.

Apparently enough time has passed that the public has forgotten what happened when psychedelics gained notoriety in the 1960s, when LSD pushed by psychiatrists spread into society as a recreational drug and started destroying lives with induced psychosis. Even the psychiatric billing bible, the Diagnostic and Statistical Manual of Mental Disorders (DSM), lists various forms of “hallucinogen intoxication” as a mental disorder so that psychiatrists can make a buck from “treating” it.

The long history of psychiatry’s attempts to promote psychedelics should give us additional clues to their harm. In the last 150 years, psychiatry has been unable to justify any cures using psychedelics. In the 1840’s French psychiatrist Jacques-Joseph Moreau promoted marijuana as a medicine. Psychedelic drugs were studied for mental health conditions in the 1950’s and 1960’s. The Multidisciplinary Association for Psychedelic Studies (MAPS) was founded in 1986 by Rick Doblin specifically to promote marijuana and psychedelics as “medicines” after his experiments using psychedelic drugs to catalyze religious experiences. In 1992, Australian psychiatrists called for heroin, cocaine and marijuana to be sold legally in liquor stores. Today, psychiatrists are embracing all things marijuana because they are getting so many patients with marijuana-related problems such as addiction and psychosis.

A surge of interest in “repurposing” psychiatric drugs for other uses has also surfaced. Researchers at Washington University School of Medicine in St. Louis announced they have launched a clinical trial in patients who have tested positive for COVID-19 but who are not sick enough to be hospitalized. The trial is investigating whether the antidepressant fluvoxamine (Luvox)–a drug linked to the Columbine High School shooting in 1999–can be repurposed for COVID-19.

The facts show psychedelics can trigger rage, violence, aggression, and precipitate various mental disorders. Whether given in a clinical setting or illegally abused, the drugs can have harmful outcomes and have no use in the mental health field.

Contact your local, state and federal officials. Let them know what you think about this, and encourage them not to fund psychedelic research.

Scientists Gave Ketamine to Sheep and were Baaaffled by the Result

Sunday, July 5th, 2020

“While studying the effects of ketamine on sheep, researchers say they found something truly strange: high doses of the drug appeared to turn the sheep’s brains off…”

First, why were they abusing sheep?

Second, we already know that ketamine is abusive to people.

And finally, we already know that ketamine, a powerful psychedelic anesthetic, is being relentlessly touted as a “new antidepressant” when in fact it just knocks you out so you don’t feel much of anything, a surefire clue that the brain has been turned off.

The same applies to Spravato (Esketamine), a nasal spray version of the anesthetic drug.

Ketamine is also known to be an illicit party drug, used by rapists to quell their victim’s movements. It’s hard to imagine how this “Club Drug” could be hailed by some psychiatrists as a potential solution for suicidal patients.

The use of ketamine to treat so-called depression is unethical and actually harmful, since it precludes the patient from finding out what is actually wrong and getting that treated. Psychiatrists pushing ketamine or esketamine are shameful drug pushers who are making a buck off people’s misfortune.

Click here for the truth they don’t want you to know about ketamine.

Ketamine for everything

Knock Yourself Out with Spravato (Esketamine)

Monday, March 18th, 2019

A nasal spray version of the anesthetic drug ketamine was approved by the FDA on March 5, 2019 for treatment-resistant depression.

Janssen Pharmaceuticals says that the cost for a one-month course of treatment for Spravato (generic esketamine) will be between $4,720 and $6,785.

Esketamine is the S-enantiomer of ketamine, which means that it is one of the two mirror images of the chemical structure of ketamine, S (for the Latin sinister) being the left image. It enhances glutamine release in the brain. Glutamine is an amino acid used in the synthesis of proteins, among other things. In the brain, glutamine is used in the production of neurotransmitters. It is believed that glutamine plays a role in raising or lowering aggression levels.

Treatment requires that doses be taken, in conjunction with an oral antidepressant, in a doctor’s office or clinic, with patients monitored for at least two hours, and their experience entered in a registry.

Because of the risk of serious adverse outcomes and the potential for abuse and misuse of the drug, it is only available through a restricted distribution system. At least you can’t take it home with you.

The Spravato labeling contains a Boxed Warning that cautions that patients are at risk for sedation and difficulty with attention, judgment and thinking (dissociation), abuse and misuse, and suicidal thoughts and behaviors after administration of the drug.

Basically, it knocks you out so you don’t feel so depressed anymore. You don’t feel much of anything, actually, since you’ve just taken an anesthetic in the snout.

There were four phase 3 clinical trials; two of them failed to show any statistical improvement, but the drug was approved anyway because it was on the Fast Track and Breakthrough Therapy paths.

A 9/5/2018 update from Consumer Reports said, “All these drugs [Ketamine, Phenylbutazone, Chloramphenicol] are prohibited in beef, poultry, and pork consumed in the U.S. Yet government data obtained by Consumer Reports suggest that trace amounts of these and other banned or severely restricted drugs may appear in the U.S. meat supply more often than was previously known.”

Note that “depression” is not an actual medical illness; it is simply a symptom of some undiagnosed and untreated condition. A diagnosis of depression is a prime example of psychiatric fraud.

Any form of ketamine used to treat so-called depression is unethical and harmful, since it precludes the patient from finding out what is actually wrong and getting that treated. Psychiatrists pushing ketamine or esketamine are shameful drug pushers who are making a buck off people’s misfortune.

Go here for more information about alternatives to drugs.